Paysign, Inc. (NASDAQ:PAYS – Get Free Report) EVP Joan Herman sold 21,004 shares of the firm’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $12.38, for a total value of $260,029.52. Following the completion of the sale, the executive vice president owned 648,321 shares of the company’s stock, valued at approximately $8,026,213.98. This trade represents a 3.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Paysign Trading Up 5.1%
Shares of Paysign stock traded up $0.60 during trading on Thursday, reaching $12.42. The company’s stock had a trading volume of 899,844 shares, compared to its average volume of 745,622. The stock has a 50-day moving average price of $11.46 and a two-hundred day moving average price of $8.01. The stock has a market capitalization of $701.23 million, a P/E ratio of 47.77 and a beta of 0.80. Paysign, Inc. has a one year low of $3.08 and a one year high of $14.43.
Paysign (NASDAQ:PAYS – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.05. Paysign had a net margin of 15.67% and a return on equity of 30.13%. The firm had revenue of $28.25 million during the quarter, compared to analysts’ expectations of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. As a group, sell-side analysts anticipate that Paysign, Inc. will post 0.58 EPS for the current fiscal year.
Institutional Investors Weigh In On Paysign
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on PAYS shares. Lake Street Capital lifted their target price on Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a research note on Tuesday. DA Davidson raised their price target on Paysign from $9.00 to $12.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Barrington Research set a $15.00 price objective on Paysign in a research report on Tuesday, August 11th. Wall Street Zen cut Paysign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 16th. Finally, Weiss Ratings raised Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, July 29th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Paysign presently has a consensus rating of “Buy” and an average price target of $14.00.
Read Our Latest Stock Report on Paysign
About Paysign
Paysign, Inc is a financial technology company that provides payment and financial services primarily to the healthcare and pharmaceutical industries. Its platform supports prepaid card programs, digital payments and other disbursement solutions designed to help organizations distribute funds to individuals efficiently and securely.
The company’s services include patient assistance programs that help eligible patients receive financial support for prescription medications and other healthcare costs.
Featured Stories
- Five stocks we like better than Paysign
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.
